Founded in 1926 in France, Guerbet is a pharmaceutical company specializing in medical imaging solutions. The group, which is still managed by the founding family, employs approximately 2,800 people and generated revenue of approximately 800 million euros in 2023.

With a presence in more than 70 countries and several production and research sites in Europe, North America, and Asia, Guerbet offers a comprehensive range of products, from contrast agents for MRI, CT, and interventional radiology to medical devices and digital solutions dedicated to imaging.